• Vision Restoration Therapy
• About the Therapy
  • FDA Clearance
• Diagnosis/Treatment
  • About Neuroplasticity
• Success Stories
• Research
• News

NovaVision™ VRT™ Now Available at Intercoastal Neurology to Treat Stroke & TBI Related Vision Loss

12/12/2005

12/12/2005 » Intercoastal Medical Group's Neurology Division Now Offers NovaVision ™ VRT ™

NovaVision ™ VRT™ is now available at Intercoastal Neurology to rehabilitate vision deficits once considered untreatable

BOCA RATON , FLORIDA — NovaVision™, Inc. today announced Intercoastal Neurology, part of Intercoastal Medical Group, Inc. of Sarasota, Fla., now offers its NovaVision™ VRT™ Vision Restoration Therapy™ (VRT™). VRT™ is an FDA-cleared, non-invasive medical device that can help restore vision lost as a result of stroke or traumatic brain injury (TBI) a condition previously considered untreatable. While speech, physical and occupational therapies are the long-standing treatment regimens for stroke and brain trauma patients, VRT™ is the first FDA-cleared clinical application of rehabilitation for vision loss.

Intercoastal Medical Group (IMG) is a professional association of 56 physicians in 14 specialties with six locations in Sarasota and Manatee counties. IMG physicians are board certified in each of their specialties and are staff members of both Sarasota Memorial Hospital and Doctor's Hospital of Sarasota.

"NovaVision™ is dedicated to expanding the accessibility of VRT™ to patients across the United States," said NovaVision™ President and CEO Navroze Mehta. "Working with leading regional medical groups like Intercoastal Neurology is essential to NovaVision's expansion of VRT™, and enables NovaVision™ to offer VRT™ to patients at local, centralized locations that maintain the quality of care and prestige found at larger NovaVision™ Partner Clinic medical institutions."

Developing the Fourth Pillar of Rehabilitation

The need for a rehabilitative therapy like VRT™ is substantial. An estimated 4.8 million people have survived a stroke (American Heart Association, 2004 Update), and at least 5.3 million Americans currently live with disabilities resulting from TBI (Centers for Disease Control and Prevention, May 2004). Approximately 1.5 million stroke and TBI patients in the United States suffer from major visual field deficits, and that number grows by more than 90,000 new patients each year. To date, more than 800 patients have been treated with VRT™ and clinical results are positive. Data from a recent retrospective study show more than 65 percent of patients who underwent VRT™ for the initial six-month treatment period demonstrated measurable improvements in their vision.

"Visual field deficits are not an uncommon physical outcome following a stroke or brain injury. If patients experienced a visual field deficit, beyond spontaneous improvement, there was no therapy to prescribe," said Intercoastal neurologist Mauricio Concha, MD. "By offering VRT™, Intercoastal Neurology has a new form of therapy that may help these patients restore visual function and potentially improve their quality of life."

VRT™ is based on the principle of neuroplasticity—the ability of partially damaged neurons in the brain to compensate for injury and adjust their activity in response to stimulation from the environment. After stroke or TBI, a zone of residual vision exists between regions within the brain's vision-processing areas. Within this zone, there are areas that can be improved using precise patterns of stimulation.

Following a clinical assessment and diagnosis at Intercoastal Neurology, VRT™ is conducted in the comfort of the patient's home with the use of a VRT™ medical device. The patient performs a customized therapy which displays stimuli on the screen in the area identified during diagnostic that shows potential for recovery. The patient responds to the stimulus while focusing on the fixation point displayed. Repeated exposure to these stimuli over an initial treatment period of approximately six to seven months may activate neurons and help improve vision, with some patients showing improvements within a few months of beginning therapy.

For more information about the NovaVision™ VRT™ clinic at Intercoastal Neurology please call 888.205.0800.